Publications by authors named "Audrey Desgranges"

Claim this Profile
O
Optimization of Adcitmer, a Monomethyl-Auristatin E bearing antibody-drug conjugate for the treatment of CD56-expressing cancers.
Aurelie Drouin, Laurine Durand, Clara Esnault, Pauline Gaboriaud, Valérie Leblond, Audrey Desgranges

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer.
Ludovic Juen, Christine B Baltus, Camille Gély, Thibault Kervarrec, Ofelia Feuillâtre, Audrey Desgranges

Bioconjug Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Drug Conjugates as an Emerging Therapy in Oncodermatology.
Clara Esnault, David Schrama, Roland Houben, Serge Guyétant, Audrey Desgranges

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model.
Ludovic Juen, Christine B Baltus, Camille Gély, Ofelia Feuillâtre, Audrey Desgranges

Bioconjug Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody-Drug Conjugates.
Ofelia Feuillâtre, Camille Gély, Steve Huvelle, Christine B Baltus, Ludovic Juen, Audrey Desgranges

ACS Omega· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis